C M Shipman

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti‐tumour activity

C M Shipman, Michael J. Rogers, Jane F. Apperley et al. · British Journal of Haematology · 1997 · 404 citations · Full text

Medicine, Oncology, Pharmacology +14

The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel

S. Jagdev, Robert E. Coleman, C M Shipman et al. · British Journal of Cancer · 2001 · 346 citations · Full text

Medicine, Oncology, Pharmacology +17

Zoledronic Acid Treatment of 5T2MM-Bearing Mice Inhibits the Development of Myeloma Bone Disease: Evidence for Decreased Osteolysis, Tumor Burden and Angiogenesis, and Increased Survival

Peter I. Croucher, Hendrik De Raeve, Mark Perry et al. · Journal of Bone and Mineral Research · 2003 · 267 citations · Full text

Medicine, Oncology, Pharmacology +17

Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.

C M Shipman, Peter I. Croucher · PubMed · 2003 · 241 citations

Life Sciences, Cell Biology, Oncology +17

The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway.

C M Shipman, Peter I. Croucher, R.G.G. Russell et al. · PubMed · 1998 · 220 citations

Medicine, Oncology, Pharmacology +13